{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:28:12Z","timestamp":1789828092562,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fibroblast growth factor 23 (FGF23) participates in the orchestration of mineral metabolism by inducing phosphaturia and decreasing the production of 1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub>. It is known that FGF23 release is stimulated by aldosterone and extracellular volume depletion. To characterize this effect further in a model of mild hypovolemia, we studied mice lacking the thiazide sensitive NaCl cotransporter (NCC). Our data indicate that NCC knockout mice (KO) have significantly higher FGF23, PTH and aldosterone concentrations than corresponding wild type (WT) mice. However, 1,25(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub>, fractional phosphate excretion and renal brush border expression of the sodium\/phosphate co-transporter 2a were not different between the two genotypes. In addition, renal expression of FGF23 receptor FGFR1 and the co-receptor Klotho were unaltered in NCC KO mice. FGF23 transcript was increased in the bone of NCC KO mice compared to WT mice, but treatment of primary murine osteoblasts with the NCC inhibitor hydrochlorothiazide did not elicit an increase of FGF23 transcription. In contrast, the mineralocorticoid receptor blocker eplerenone reversed excess FGF23 levels in KO mice but not in WT mice, indicating that FGF23 upregulation in NCC KO mice is primarily aldosterone-mediated. Together, our data reveal that lack of renal NCC causes an aldosterone-mediated upregulation of circulating FGF23.<\/jats:p>","DOI":"10.1038\/s41598-018-22041-1","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T16:09:39Z","timestamp":1519142979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Elevated FGF23 Levels in Mice Lacking the Thiazide-Sensitive NaCl cotransporter (NCC)"],"prefix":"10.1038","volume":"8","author":[{"given":"Ganesh","family":"Pathare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8449-0232","authenticated-orcid":false,"given":"Manuel","family":"Anderegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2962-1540","authenticated-orcid":false,"given":"Florian","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"22041_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/en.2010-0800","volume":"152","author":"M Hori","year":"2011","unstructured":"Hori, M., Shimizu, Y. & Fukumoto, S. Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism. Endocrinology 152, 4\u201310 (2011).","journal-title":"Endocrinology"},{"key":"22041_CR2","doi-asserted-by":"publisher","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","volume":"297","author":"J Gattineni","year":"2009","unstructured":"Gattineni, J. et al. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 297, F282\u2013291 (2009).","journal-title":"Am J Physiol Renal Physiol"},{"key":"22041_CR3","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1681\/ASN.2007121301","volume":"19","author":"S Liu","year":"2008","unstructured":"Liu, S., Vierthaler, L., Tang, W., Zhou, J. & Quarles, L. D. FGFR3 and FGFR4 do not mediate renal effects of FGF23. J Am Soc Nephrol 19, 2342\u20132350 (2008).","journal-title":"J Am Soc Nephrol"},{"key":"22041_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"MC Hu","year":"2013","unstructured":"Hu, M. C., Shiizaki, K., Kuro-o, M. & Moe, O. W. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 75, 503\u2013533, https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183727 (2013).","journal-title":"Annu Rev Physiol"},{"key":"22041_CR5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bone.2012.05.015","volume":"51","author":"O Andrukhova","year":"2012","unstructured":"Andrukhova, O. et al. FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2-SGK1 signaling pathway. Bone 51, 621\u2013628, https:\/\/doi.org\/10.1016\/j.bone.2012.05.015 (2012).","journal-title":"Bone"},{"key":"22041_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada, T. et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin. Invest 113, 561\u2013568 (2004).","journal-title":"J Clin. Invest"},{"key":"22041_CR7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ki.2013.534","volume":"85","author":"F Lang","year":"2014","unstructured":"Lang, F. & F\u00f6ller, M. Enigmatic Cassandra: renal FGF23 formation in polycystic kidney disease. Kidney Int 85, 1260\u20131262 (2014).","journal-title":"Kidney Int"},{"key":"22041_CR8","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1172\/JCI64184","volume":"122","author":"OW Moe","year":"2012","unstructured":"Moe, O. W. Fibroblast growth factor 23: friend or foe in uremia? The Journal of clinical investigation 122, 2354\u20132356, https:\/\/doi.org\/10.1172\/JCI64184 (2012).","journal-title":"The Journal of clinical investigation"},{"key":"22041_CR9","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul, C. et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 121, 4393\u20134408 (2011).","journal-title":"J Clin Invest"},{"key":"22041_CR10","doi-asserted-by":"publisher","first-page":"02014","DOI":"10.1152\/ajpheart.00331.2014","volume":"00331","author":"M Imazu","year":"2014","unstructured":"Imazu, M. et al. Pathophysiological Impact of Serum Fibroblast Growth Factor 23 in Patients with Non-ischemic Cardiac Disease and Early Chronic Kidney Disease. American journal of physiology. Heart and circulatory physiology, ajpheart 00331, 02014, https:\/\/doi.org\/10.1152\/ajpheart.00331.2014 (2014).","journal-title":"American journal of physiology. Heart and circulatory physiology, ajpheart"},{"key":"22041_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/01.mnh.0000447021.51722.2f","volume":"23","author":"M Christov","year":"2014","unstructured":"Christov, M. Fibroblast growth factor 23 in acute kidney injury. Current opinion in nephrology and hypertension 23, 340\u2013345, https:\/\/doi.org\/10.1097\/01.mnh.0000447021.51722.2f (2014).","journal-title":"Current opinion in nephrology and hypertension"},{"key":"22041_CR12","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.2215\/CJN.08241109","volume":"5","author":"P Evenepoel","year":"2010","unstructured":"Evenepoel, P. et al. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clinical journal of the American Society of Nephrology: CJASN 5, 1268\u20131276, https:\/\/doi.org\/10.2215\/CJN.08241109 (2010).","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"22041_CR13","doi-asserted-by":"publisher","first-page":"e70775","DOI":"10.1371\/journal.pone.0070775","volume":"8","author":"C Zanchi","year":"2013","unstructured":"Zanchi, C. et al. Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ace inhibitor. PloS one 8, e70775, https:\/\/doi.org\/10.1371\/journal.pone.0070775 (2013).","journal-title":"PloS one"},{"key":"22041_CR14","doi-asserted-by":"publisher","first-page":"e66182","DOI":"10.1371\/journal.pone.0066182","volume":"8","author":"D Prie","year":"2013","unstructured":"Prie, D. et al. Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list. PloS one 8, e66182, https:\/\/doi.org\/10.1371\/journal.pone.0066182 (2013).","journal-title":"PloS one"},{"key":"22041_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.kint.2016.04.024","volume":"90","author":"NA Dhayat","year":"2016","unstructured":"Dhayat, N. A. et al. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. Kidney Int 90, 648\u2013657 (2016).","journal-title":"Kidney Int"},{"key":"22041_CR16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","volume":"6","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova, O. et al. FGF23 regulates renal sodium handling and blood pressure. EMBO Mol Med 6, 744\u2013759 (2014).","journal-title":"EMBO Mol Med"},{"key":"22041_CR17","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1093\/ndt\/gfv393","volume":"31","author":"JK Humalda","year":"2016","unstructured":"Humalda, J. K. et al. Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis. Nephrol Dial Transplant 31, 1494\u20131501, https:\/\/doi.org\/10.1093\/ndt\/gfv393 (2016).","journal-title":"Nephrol Dial Transplant"},{"key":"22041_CR18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1161\/01.CIR.24.5.1197","volume":"24","author":"RW Gifford Jr.","year":"1961","unstructured":"Gifford, R. W. Jr., Mattox, V. R., Orvis, A. L., Sones, D. A. & Rosevear, J. W. Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension. Circulation 24, 1197\u20131205 (1961).","journal-title":"Circulation"},{"key":"22041_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1359\/JBMR.041238","volume":"20","author":"L Nicolet-Barousse","year":"2005","unstructured":"Nicolet-Barousse, L. et al. Inactivation of the Na-Cl co-transporter (NCC) gene is associated with high BMD through both renal and bone mechanisms: analysis of patients with Gitelman syndrome and Ncc null mice. J Bone Miner Res 20, 799\u2013808 (2005).","journal-title":"J Bone Miner Res"},{"key":"22041_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.bbrc.2016.01.034","volume":"470","author":"B Zhang","year":"2016","unstructured":"Zhang, B. et al. Up-regulation of FGF23 release by aldosterone. Biochem Biophys Res Commun 470, 384\u2013390, https:\/\/doi.org\/10.1016\/j.bbrc.2016.01.034 (2016).","journal-title":"Biochem Biophys Res Commun"},{"key":"22041_CR21","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1172\/JCI200319826","volume":"112","author":"JG Hoenderop","year":"2003","unstructured":"Hoenderop, J. G. et al. Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J Clin Invest 112, 1906\u20131914, https:\/\/doi.org\/10.1172\/JCI19826 (2003).","journal-title":"J Clin Invest"},{"key":"22041_CR22","doi-asserted-by":"crossref","unstructured":"Zhang, B. et al NF\u03baB-sensitive Orai1 expression in the regulation of FGF23 release. J Mol Med (Berl) in press (2015).","DOI":"10.1007\/s00109-015-1370-3"},{"key":"22041_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00424-013-1340-y","volume":"466","author":"H Fakhri","year":"2014","unstructured":"Fakhri, H. et al. Regulation of mineral metabolism by lithium. Pflugers Arch 466, 467\u2013475, https:\/\/doi.org\/10.1007\/s00424-013-1340-y (2014).","journal-title":"Pflugers Arch"},{"key":"22041_CR24","doi-asserted-by":"publisher","first-page":"29150","DOI":"10.1074\/jbc.273.44.29150","volume":"273","author":"PJ Schultheis","year":"1998","unstructured":"Schultheis, P. J. et al. Phenotype resembling Gitelman\u2019s syndrome in mice lacking the apical Na+-Cl\u2212 cotransporter of the distal convoluted tubule. J Biol Chem 273, 29150\u201329155 (1998).","journal-title":"J Biol Chem"},{"key":"22041_CR25","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1681\/ASN.2007030348","volume":"18","author":"MM Dvorak","year":"2007","unstructured":"Dvorak, M. M. et al. Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. J Am Soc Nephrol 18, 2509\u20132516 (2007).","journal-title":"J Am Soc Nephrol"},{"key":"22041_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jbmr.2306","volume":"30","author":"YJ Hsu","year":"2015","unstructured":"Hsu, Y. J. et al. Thiazide-sensitive Na+-Cl\u2212 cotransporter (NCC) gene inactivation results in increased duodenal Ca2+ absorption, enhanced osteoblast differentiation and elevated bone mineral density. J Bone Miner Res 30, 116\u2013127, https:\/\/doi.org\/10.1002\/jbmr.2306 (2015).","journal-title":"J Bone Miner Res"},{"key":"22041_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000343393","volume":"36","author":"G Pathare","year":"2012","unstructured":"Pathare, G. et al. Enhanced FGF23 serum concentrations and phosphaturia in gene targeted mice expressing WNK-resistant SPAK. Kidney Blood Press Res 36, 355\u2013364, https:\/\/doi.org\/10.1159\/000343393 (2012).","journal-title":"Kidney Blood Press Res"},{"key":"22041_CR28","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1681\/ASN.2009121295","volume":"21","author":"SS Yang","year":"2010","unstructured":"Yang, S. S. et al. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol 21, 1868\u20131877, https:\/\/doi.org\/10.1681\/ASN.2009121295 (2010).","journal-title":"J Am Soc Nephrol"},{"key":"22041_CR29","doi-asserted-by":"publisher","first-page":"17538","DOI":"10.1073\/pnas.1107452108","volume":"108","author":"SH Lin","year":"2011","unstructured":"Lin, S. H. et al. Impaired phosphorylation of Na(+)-K(+)-2Cl(\u2212) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome. Proc Natl Acad Sci USA 108, 17538\u201317543, https:\/\/doi.org\/10.1073\/pnas.1107452108 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"22041_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000343405","volume":"36","author":"G Pathare","year":"2012","unstructured":"Pathare, G. et al. OSR1-sensitive renal tubular phosphate reabsorption. Kidney Blood Press Res 36, 149\u2013161, https:\/\/doi.org\/10.1159\/000343405 (2012).","journal-title":"Kidney Blood Press Res"},{"key":"22041_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11906-012-0256-9","volume":"14","author":"AS Mihailidou","year":"2012","unstructured":"Mihailidou, A. S. Aldosterone in heart disease. Current hypertension reports 14, 125\u2013129, https:\/\/doi.org\/10.1007\/s11906-012-0256-9 (2012).","journal-title":"Current hypertension reports"},{"key":"22041_CR32","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2215\/CJN.03150509","volume":"4","author":"M Sarraf","year":"2009","unstructured":"Sarraf, M., Masoumi, A. & Schrier, R. W. Cardiorenal syndrome in acute decompensated heart failure. Clinical journal of the American Society of Nephrology: CJASN 4, 2013\u20132026, https:\/\/doi.org\/10.2215\/CJN.03150509 (2009).","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"22041_CR33","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.amjmed.2006.05.007","volume":"119","author":"RW Schrier","year":"2006","unstructured":"Schrier, R. W. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. The American journal of medicine 119, S47\u201353, https:\/\/doi.org\/10.1016\/j.amjmed.2006.05.007 (2006).","journal-title":"The American journal of medicine"},{"key":"22041_CR34","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/ndt\/gft041","volume":"28","author":"F Lang","year":"2013","unstructured":"Lang, F., Ritz, E., Voelkl, J. & Alesutan, I. Vascular calcification\u2013is aldosterone a culprit? Nephrol. Dial. Transplant. 28, 1080\u20131084 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"22041_CR35","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3109\/0886022X.2012.672156","volume":"34","author":"TK Ma","year":"2012","unstructured":"Ma, T. K. & Szeto, C. C. Mineralocorticoid receptor antagonist for renal protection. Renal failure 34, 810\u2013817, https:\/\/doi.org\/10.3109\/0886022X.2012.672156 (2012).","journal-title":"Renal failure"},{"key":"22041_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MNH.0b013e3283414ca1","volume":"20","author":"E Ritz","year":"2011","unstructured":"Ritz, E., Koleganova, N. & Piecha, G. Is there an obesity-metabolic syndrome related glomerulopathy? Current opinion in nephrology and hypertension 20, 44\u201349, https:\/\/doi.org\/10.1097\/MNH.0b013e3283414ca1 (2011).","journal-title":"Current opinion in nephrology and hypertension"},{"key":"22041_CR37","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.2215\/CJN.01410210","volume":"5","author":"RW Schrier","year":"2010","unstructured":"Schrier, R. W., Masoumi, A. & Elhassan, E. Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome. Clinical journal of the American Society of Nephrology: CJASN 5, 1132\u20131140, https:\/\/doi.org\/10.2215\/CJN.01410210 (2010).","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"22041_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1152\/physrev.00002.2011","volume":"92","author":"A Martin","year":"2012","unstructured":"Martin, A., David, V. & Quarles, L. D. Regulation and function of the FGF23\/klotho endocrine pathways. Physiol Rev 92, 131\u2013155, https:\/\/doi.org\/10.1152\/physrev.00002.2011 (2012).","journal-title":"Physiol Rev"},{"key":"22041_CR39","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/bonekey.2015.74","volume":"4","author":"RB Brown","year":"2015","unstructured":"Brown, R. B. & Razzaque, M. S. Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity. Bonekey Rep 4, 705, https:\/\/doi.org\/10.1038\/bonekey.2015.74 (2015).","journal-title":"Bonekey Rep"},{"key":"22041_CR40","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1210\/en.2016-1451","volume":"158","author":"VM Knab","year":"2017","unstructured":"Knab, V. M. et al. Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels. Endocrinology 158, 1130\u20131139 (2017).","journal-title":"Endocrinology"},{"key":"22041_CR41","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1074\/jbc.M807610200","volume":"284","author":"Y Izu","year":"2009","unstructured":"Izu, Y. et al. Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem 284, 4857\u20134864, https:\/\/doi.org\/10.1074\/jbc.M807610200 (2009).","journal-title":"J Biol Chem"},{"key":"22041_CR42","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","volume":"16","author":"S Beavan","year":"2001","unstructured":"Beavan, S., Horner, A., Bord, S., Ireland, D. & Compston, J. Colocalization of glucocorticoid and mineralocorticoid receptors in human bone. J Bone Miner Res 16, 1496\u20131504, https:\/\/doi.org\/10.1359\/jbmr.2001.16.8.1496 (2001).","journal-title":"J Bone Miner Res"},{"key":"22041_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ceca.2012.05.005","volume":"52","author":"F Lang","year":"2012","unstructured":"Lang, F., Eylenstein, A. & Shumilina, E. Regulation of Orai1\/STIM1 by the kinases SGK1 and AMPK. Cell Calcium 52, 347\u2013354, https:\/\/doi.org\/10.1016\/j.ceca.2012.05.005 (2012).","journal-title":"Cell Calcium"},{"key":"22041_CR44","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1681\/ASN.2015070734","volume":"28","author":"A Sinning","year":"2017","unstructured":"Sinning, A. et al. Double Knockout of the Na+-Driven Cl\u2212\/HCO3\u2212 Exchanger and Na+\/Cl\u2212 Cotransporter Induces Hypokalemia and Volume Depletion. J Am Soc Nephrol 28, 130\u2013139 (2017).","journal-title":"J Am Soc Nephrol"},{"key":"22041_CR45","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1046\/j.1523-1755.1999.00395.x","volume":"55","author":"A Jara","year":"1999","unstructured":"Jara, A. et al. Phosphate depletion in the rat: effect of bisphosphonates and the calcemic response to PTH. Kidney Int 55, 1434\u20131443, https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00395.x (1999).","journal-title":"Kidney Int"},{"key":"22041_CR46","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0002-9343(00)00510-6","volume":"109","author":"IR Reid","year":"2000","unstructured":"Reid, I. R. et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 109, 362\u2013370 (2000).","journal-title":"Am J Med"},{"key":"22041_CR47","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM198308113090605","volume":"309","author":"RD Wasnich","year":"1983","unstructured":"Wasnich, R. D., Benfante, R. J., Yano, K., Heilbrun, L. & Vogel, J. M. Thiazide effect on the mineral content of bone. N Engl J Med 309, 344\u2013347, https:\/\/doi.org\/10.1056\/NEJM198308113090605 (1983).","journal-title":"N Engl J Med"},{"key":"22041_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0026-0495(78)90158-0","volume":"27","author":"DE Barilla","year":"1978","unstructured":"Barilla, D. E., Tolentino, R., Kaplan, R. A. & Pak, C. Y. Selective effects of thiazide on intestinal absorption of calcium and adsorptive and renal hypercalciurias. Metabolism 27, 125\u2013131 (1978).","journal-title":"Metabolism"},{"key":"22041_CR49","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1210\/jcem-59-6-1037","volume":"59","author":"K Sakhaee","year":"1984","unstructured":"Sakhaee, K., Nicar, M. J., Glass, K., Zerwekh, J. E. & Pak, C. Y. Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis. J Clin Endocrinol Metab 59, 1037\u20131043, https:\/\/doi.org\/10.1210\/jcem-59-6-1037 (1984).","journal-title":"J Clin Endocrinol Metab"},{"key":"22041_CR50","doi-asserted-by":"publisher","first-page":"F592","DOI":"10.1152\/ajprenal.00116.2013","volume":"305","author":"KJ Bergsland","year":"2013","unstructured":"Bergsland, K. J., Worcester, E. M. & Coe, F. L. Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am J Physiol Renal Physiol 305, F592\u2013599, https:\/\/doi.org\/10.1152\/ajprenal.00116.2013 (2013).","journal-title":"Am J Physiol Renal Physiol"},{"key":"22041_CR51","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.11622\/smedj.2013020","volume":"54","author":"A Ali","year":"2013","unstructured":"Ali, A., Masood, Q., Yaqub, S. & Kashif, W. A case of Gitelman syndrome with severe hyponatraemia and hypophosphataemia. Singapore Med J 54, e18\u201320 (2013).","journal-title":"Singapore Med J"},{"key":"22041_CR52","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1093\/oxfordjournals.ndt.a027107","volume":"11","author":"K Katopodis","year":"1996","unstructured":"Katopodis, K., Elisaf, M. & Siamopoulos, K. C. Hypophosphataemia in a patient with Gitelman\u2019s syndrome. Nephrol Dial Transplant 11, 2090\u20132092 (1996).","journal-title":"Nephrol Dial Transplant"},{"key":"22041_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00467-012-2297-3","volume":"28","author":"C Vigano","year":"2013","unstructured":"Vigano, C. et al. Renal phosphate handling in Gitelman syndrome\u2013the results of a case-control study. Pediatr Nephrol 28, 65\u201370, https:\/\/doi.org\/10.1007\/s00467-012-2297-3 (2013).","journal-title":"Pediatr Nephrol"},{"key":"22041_CR54","unstructured":"Akhtar, N. & Hafeez, F. A rare case of Gitelman\u2019s syndrome with hypophosphatemia. J Coll Physicians Surg Pak 19, 257\u2013259, doi:04.2009\/JCPSP.257259 (2009)."},{"key":"22041_CR55","doi-asserted-by":"crossref","unstructured":"Vallon, V. In vivo studies of the genetically modified mouse kidney. Nephron Physiol 94, p1\u20135, doi:71068 (2003).","DOI":"10.1159\/000071068"},{"key":"22041_CR56","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bone.2006.02.056","volume":"39","author":"R Balga","year":"2006","unstructured":"Balga, R. et al. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Bone 39, 325\u2013335, https:\/\/doi.org\/10.1016\/j.bone.2006.02.056 (2006).","journal-title":"Bone"},{"key":"22041_CR57","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1042\/bj1420575","volume":"142","author":"AG Booth","year":"1974","unstructured":"Booth, A. G. & Kenny, A. J. A rapid method for the preparation of microvilli from rabbit kidney. Biochem J 142, 575\u2013581 (1974).","journal-title":"Biochem J"},{"key":"22041_CR58","doi-asserted-by":"publisher","first-page":"e0125104","DOI":"10.1371\/journal.pone.0125104","volume":"10","author":"G Albano","year":"2015","unstructured":"Albano, G. et al. Sodium-dependent phosphate transporters in osteoclast differentiation and function. PLoS One 10, e0125104 (2015).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22041-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22041-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22041-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:46:07Z","timestamp":1671590767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22041-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22041"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22041-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"6 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3590"}}